Please wait while the formulary information is being retrieved.
GANIRELIX ACETATE (GANIRELIX ACETATE)
- Prevention of LH surge in ovarian hyperstimulation
ganirelix 250 mcg/0.5 mL subcutaneous syringe
- Inject 0.5 milliliter (250 mcg) by subcutaneous route once daily
Prevention of LH surge in ovarian hyperstimulation
- Inject 0.5 milliliter (250 mcg) by subcutaneous route once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- Lactating mother
- Pregnancy
Contraindicated
- None
Severe
Moderate
- None
GANIRELIX ACETATE (GANIRELIX ACETATE)
- Prevention of LH surge in ovarian hyperstimulation
- None
- None
More Frequent
Severe
Less Severe
- Ovarian hyperstimulation syndrome
- Abnormal vaginal bleeding
- Acute abdominal pain
- Drug-induced hot flash
- Dyspnea
- Fatigue
- Headache disorder
- Injection site sequelae
- Nausea
- Pain
- Rhinitis
- Upper respiratory infection
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Angioedema
- Facial edema
- Hypersensitivity drug reaction
Less Severe
- Dizziness
- Urticaria
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Cetrorelix, Ganirelix
No relevant indication for use in children.
- 1 Day – 18 Years
- No relevant indication for use in children.
Ganirelix
- Severity Level:
X
- Additional Notes:
Contraindicated
Ganirelix
Contraindicated in lactating women
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Contraindicated in lactating women |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Prevention of LH surge in ovarian hyperstimulation | |
| Z31.83 | Encounter for assisted reproductive fertility procedure cycle |
| Z31.89 | Encounter for other procreative management |
| 0-9 | A-Z |
|---|---|
| Z31.83 | Encounter for assisted reproductive fertility procedure cycle |
| Z31.89 | Encounter for other procreative management |
Formulary Reference Tool